cancer disparitiescancer incidencecancer mortalitycancer preventionpopulation-based cancer registries
Figures from the paper
Abstract (AI)
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries (through 2020) and mortality data collected by the National Center for Health Statistics (through 2021). In 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both the adjuvant and metastatic settings. However, these gains are threatened by increasing incidence for 6 of the top 10 cancers. Incidence rates increased during 2015-2019 by 0.6%-1% annually for breast, pancreas, and uterine corpus cancers and by 2%-3% annually for prostate, liver (female), kidney, and human papillomavirus-associated oral cancers and for melanoma. Incidence rates also increased by 1%-2% annually for cervical (ages 30-44 years) and colorectal cancers (ages <55 years) in young adults. Colorectal cancer was the fourth-leading cause of cancer death in both men and women younger than 50 years in the late-1990s but is now first in men and second in women. Progress is also hampered by wide persistent cancer disparities; compared to White people, mortality rates are two-fold higher for prostate, stomach and uterine corpus cancers in Black people and for liver, stomach, and kidney cancers in Native American people. Continued national progress will require increased investment in cancer prevention and access to equitable treatment, especially among American Indian and Alaska Native and Black individuals.
Key Findings
1
Cancer incidence increased during 2015–2019 for six of the ten most common cancers, including breast, pancreatic, uterine corpus, prostate, liver, kidney, oral, and melanoma cancers.
2
Cancer mortality continued declining through 2021, averting over 4 million deaths since 1991 through reduced smoking, earlier detection, and improved treatments.
3
Incidence of cervical cancer among women aged 30–44 years and colorectal cancer among adults younger than 55 increased annually, while colorectal cancer became the leading cancer death cause in men younger than 50.
4
Persistent disparities remain substantial: mortality is approximately twice as high among Black or Native American people for several major cancers, highlighting the need for prevention and equitable treatment access.
5
The United States is projected to experience 2,001,140 new cancer cases and 611,720 cancer deaths in 2024.
Research Object
Cancer incidence and mortality in the United States (population-level cancer occurrence and outcomes)
Research Subject
Recent and projected cancer incidence and mortality trends, including disparities and factors affecting national progress
Publication Details
Publication Date
2024-01-01
Journal
Publisher
ISSN
Cited by
12549
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai1
Cited by9
Breast cancer: pathogenesis and treatments2025
Cancer stem cells: advances in knowledge and implications for cancer therapy2024
Projected Lifetime Cancer Risks From Current Computed Tomography Imaging2025
Hepatocellular carcinoma: signaling pathways and therapeutic advances2025
Aging and cancer2024
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer2025
Pan-cancer bioinformatics indicates zinc finger protein 207 is a promising prognostic biomarker and immunotherapeutic target2024
Targeting the DNA methylation–H3K27me3 switch reverses castration resistance and immunosuppression via ADAMTS1-driven collagenolysis2026
Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-20202024